Argonaut Therapeutics

Description: Oxford spin-out developing PRMT5 inhibitors & diagnostics for precision cancer treatment, based on arginine methylation research.

Country: UK

Based in: Oxford, Oxfordshire

Founded: 2016

Funding Stage: Series A/B

Tags: ['Health Care', 'Therapeutics']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.